Correlation between reactive oxygen metabolites & atherosclerotic risk factors in patients with type 2 diabetes mellitus

Indian Journal of Medical Research

Volumn 137, Issue 4, 2013, Pages 742-748

  Kotani, Kazuhiko ^a,b   Tsuzaki, Kokoro ^b   Taniguchi, Nobuyuki ^a   Sakane, Naoki ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

Atherosclerotic risk factor; Blood pressure; D ROMS test; HDL cholesterol; Hypertension; Oxidative stress

Indexed keywords

CHOLESTEROL; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RISK FACTOR; SAMPLE SIZE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS; STATISTICS AS TOPIC;

EID: 84877735327     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ali MK, Narayan KM, Tandon N. Diabetes & coronary heart disease: current perspectives. Indian J Med Res 2010; 132: 584-97.
2. Kumar S, Mukherjee S, Mukhopadhyay P, Pandit K, Raychaudhuri M, Sengupta N, et al. Prevalence of diabetes and impaired fasting glucose in a selected population with special reference to influence of family history and anthropometric measurements-the Kolkata policeman study. J Assoc Physicians India 2008; 56: 841-4.
3. Taskinen MR. Diabetic dyslipidemia. Atheroscler Suppl 2002; 3: 47-51.
4. Ko SH, Cao W, Liu Z. Hypertension management and microvascular insulin resistance in diabetes. Curr Hypertens Rep 2010; 12: 243-51.
5. Piconi L, Quagliaro L, Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 2003; 41: 1144-9.
6. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009; 202: 321-9.
7. Iamele L, Fiocchi R, Vernocchi A. Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med 2002; 40: 673-6.
8. Vîrgolici B, Mohora M, Stoian I, Lixandru D, Gǎman L, Paveliu F. A comparative oxidative stress study-obesity with and without diabetes mellitus. Rom J Intern Med 2005; 43: 261-8.
9. Vassalle C. An easy and reliable automated method to estimate oxidative stress in the clinical setting. Methods Mol Biol 2008; 477: 31-9.
10. Kotani K, Sakane N, Tsuzaki K, Matsuoka Y, Sano Y, Hamada T, et al. Lifestyles and oxidative stress in type 2 diabetic patients. Scand J Clin Lab Invest 2008; 68: 516-8.
11. Hirose H, Kawabe H, Komiya N, Saito I. Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb 2009; 16: 77-82.
12. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. World Health Organization, Geneva, 2006.
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31 (Suppl 1): S55-60.
14. Bonnefont-Rousselot D, Raji B, Walrand S, Gardès-Albert M, Jore D, Legrand A, et al. An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism 2003; 52: 586-9.
15. Rösen P, Wiernsperger NF. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress. Diabetes Metab Res Rev 2006; 22: 323-30.
16. Smith A. The treatment of hypertension in patients with diabetes. Nurs Clin North Am 2001; 36: 273-89.
17. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 1997; 17: 107-13.
18. Van Linthout S, Spillmann F, Schultheiss HP, Tschöpe C. High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders. Curr Pharm Des 2010; 16: 1504-16.
19. John S, Schmieder RE. Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Curr Hypertens Rep 2003; 5: 199-207.
20. Madamanchi NR, Hakim ZS, Runge MS. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J Thromb Haemost 2005; 3: 254-67.
21. Lassègue B, Griendling KK. Reactive oxygen species in hypertension; An update. Am J Hypertens 2004; 17: 852-60.
22. Rodrigo R, González J, Paoletto F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens Res 2011; 34: 431-40.
23. Kim JK, Alley D, Seeman T, Karlamangla A, Crimmins E. Recent changes in cardiovascular risk factors among women and men. J Womens Health (Larchmt) 2006; 15: 734-46.
24. Mohan V, Goldhaber-Fiebert JD, Radha V, Gokulakrishnan K. Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians. Indian J Med Res 2011; 133: 294-9.